The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice

被引:4
作者
Gebrael, Georges [1 ]
Thomas, Vinay Mathew [1 ]
Swami, Umang [1 ]
Agarwal, Neeraj [1 ,2 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Dept Internal Med, Div Oncol, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, NCI CCC, 2000 Circle Hope Dr Suite 5726, Salt Lake City, UT 84112 USA
关键词
MCSPC;
D O I
10.1093/oncolo/oyad047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This commentary highlights 2 international studies on real-world treatment trends and patterns among patients with metastatic castration-sensitive and resistant prostate cancer and how interventions targeting physicians and patients can bridge the gap between evidence-based medicine and real-world practice.
引用
收藏
页码:746 / 749
页数:4
相关论文
共 22 条
[1]   Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study [J].
Agarwal, Neeraj ;
McQuarrie, Kelly ;
Bjartell, Anders ;
Chowdhury, Simon ;
Pereira de Santana Gomes, Andrea J. ;
Chung, Byung Ha ;
Ozguroglu, Mustafa ;
Juarez Soto, Alvaro ;
Merseburger, Axel S. ;
Uemura, Hirotsugu ;
Ye, Dingwei ;
Given, Robert ;
Cella, David ;
Basch, Ethan ;
Miladinovic, Branko ;
Dearden, Lindsay ;
Deprince, Kris ;
Naini, Vahid ;
Lopez-Gitlitz, Angela ;
Chi, Kim N. .
LANCET ONCOLOGY, 2019, 20 (11) :1518-1530
[2]   Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer [J].
Armstrong, Andrew J. ;
Azad, Arun A. ;
Iguchi, Taro ;
Szmulewitz, Russell Z. ;
Petrylak, Daniel P. ;
Holzbeierlein, Jeffrey ;
Villers, Arnauld ;
Alcaraz, Antonio ;
Alekseev, Boris ;
Shore, Neal D. ;
Gomez-Veiga, Francisco ;
Rosbrook, Brad ;
Zohren, Fabian ;
Yamada, Shunsuke ;
Haas, Gabriel P. ;
Stenzl, Arnulf .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) :1616-+
[3]  
Barata P., ONCOLOGIST
[4]   Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study [J].
Chi, Kim N. ;
Chowdhury, Simon ;
Bjartell, Anders ;
Byung Ha Chung ;
Gomes, Andrea J. Pereira de Santana ;
Given, Robert ;
Juarez, Alvaro ;
Merseburger, Axel S. ;
Ozguroglu, Mustafa ;
Uemura, Hirotsugu ;
Ye, Dingwei ;
Brookman-May, Sabine ;
Mundle, Suneel D. ;
McCarthy, Sharon A. ;
Larsen, Julie S. ;
Sun, Weili ;
Bevans, Katherine B. ;
Zhang, Ke ;
Bandyopadhyay, Nibedita ;
Agarwal, Neeraj .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) :2294-+
[5]   Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer [J].
Chi, Kim N. ;
Agarwal, Neeraj ;
Bjartell, Anders ;
Chung, Byung Ha ;
Pereira de Santana Gomes, Andrea J. ;
Given, Robert ;
Juarez Soto, Alvaro ;
Merseburger, Axel S. ;
Ozguroglu, Mustafa ;
Uemura, Hirotsugu ;
Ye, Dingwei ;
Deprince, Kris ;
Naini, Vahid ;
Li, Jinhui ;
Cheng, Shinta ;
Yu, Margaret K. ;
Zhang, Ke ;
Larsen, Julie S. ;
McCarthy, Sharon ;
Chowdhury, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) :13-24
[6]   Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer [J].
Davis, Ian D. ;
Martin, Andrew J. ;
Stockler, Martin R. ;
Begbie, Stephen ;
Chi, Kim N. ;
Chowdhury, Simon ;
Coskinas, Xanthi ;
Frydenberg, Mark ;
Hague, Wendy E. ;
Horvath, Lisa G. ;
Joshua, Anthony M. ;
Lawrence, Nicola J. ;
Marx, Gavin ;
McCaffrey, John ;
McDermott, Ray ;
McJannett, Margaret ;
North, Scott A. ;
Parnis, Francis ;
Parulekar, Wendy ;
Pook, David W. ;
Reaume, M. Neil ;
Sandhu, Shahneen K. ;
Tan, Alvin ;
Tan, T. Hsiang ;
Thomson, Alastair ;
Tu, Emily ;
Vera-Badillo, Francisco ;
Williams, Scott G. ;
Yip, Sonia ;
Zhang, Alison Y. ;
Zielinski, Robert R. ;
Sweeney, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) :121-131
[7]   Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design [J].
Fizazi, Karim ;
Foulon, Stephanie ;
Carles, Joan ;
Roubaud, Guilhem ;
McDermott, Ray ;
Flechon, Aude ;
Tombal, Bertrand ;
Supiot, Stephane ;
Berthold, Dominik ;
Ronchin, Philippe ;
Kacso, Gabriel ;
Gravis, Gwenaelle ;
Calabro, Fabio ;
Berdah, Jean-Francois ;
Hasbini, Ali ;
Silva, Marlon ;
Thiery-Vuillemin, Antoine ;
Latorzeff, Igor ;
Mourey, Loic ;
Laguerre, Brigitte ;
Abadie-Lacourtoisie, Sophie ;
Martin, Etienne ;
El Kouri, Claude ;
Escande, Anne ;
Rosello, Alvar ;
Magne, Nicolas ;
Schlurmann, Friederike ;
Priou, Frank ;
Chand-Fouche, Marie-Eve ;
Freixa, Salvador Villa ;
Jamaluddin, Muhammad ;
Rieger, Isabelle ;
Bossi, Alberto .
LANCET, 2022, 399 (10336) :1695-1707
[8]   Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial [J].
Fizazi, Karim ;
NamPhuong Tran ;
Fein, Luis ;
Matsubara, Nobuaki ;
Rodriguez-Antolin, Alfredo ;
Alekseev, Boris Y. ;
Ozguroglu, Mustafa ;
Ye, Dingwei ;
Feyerabend, Susan ;
Protheroe, Andrew ;
Sulur, Giri ;
Luna, Yesenia ;
Li, Susan ;
Mundle, Suneel ;
Chi, Kim N. .
LANCET ONCOLOGY, 2019, 20 (05) :686-700
[9]   Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer [J].
Fizazi, Karim ;
NamPhuong Tran ;
Fein, Luis ;
Matsubara, Nobuaki ;
Rodriguez-Antolin, Alfredo ;
Alekseev, Boris Y. ;
Ozguroglu, Mustafa ;
Ye, Dingwei ;
Feyerabend, Susan ;
Protheroe, Andrew ;
De Porre, Peter ;
Kheoh, Thian ;
Park, Youn C. ;
Todd, Mary B. ;
Chi, Kim N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :352-360
[10]  
Freedland SJ, 2022, J CLIN ONCOL, V40